Akt and Mitogen-Activated Protein Kinase signaling pathways (Akt/MAPK pathways)

The Akt and Mitogen-Activated Protein Kinase (MAPK) signaling pathways are two of the most critical intracellular communication networks regulating fundamental cellular processes such as growth, proliferation, survival, and metabolic homeostasis [1][2]. The Akt pathway, often integrated with PI3K and mTOR, is primarily activated by growth factors and insulin, serving as a central regulator of glucose metabolism and anti-apoptotic signaling [3]. Conversely, the MAPK pathway (specifically the Ras/Raf/MEK/ERK cascade) typically responds to mitogenic stimuli to govern cell cycle entry, differentiation, and stress responses [4]. Dysregulation of these pathways, frequently through gain-of-function mutations in components like PIK3CA, BRAF, or KRAS, is a hallmark of human oncogenesis and contributes to chemotherapy resistance [5]. From a therapeutic perspective, while numerous inhibitors targeting specific nodes within these pathways are FDA-approved, the high degree of crosstalk and compensatory feedback between the Akt and MAPK axes often necessitates combination strategies to prevent adaptive resistance [6]. Sources: [1] Manning & Toker (2017) Cell; [2] Cargnello & Roux (2011) Microbiol Mol Biol Rev; [3] Yuan & Cantley (2008) Oncogene; [4] Burotto et al. (2014) Cancer; [5] McCubrey et al. (2007) Leukemia; [6] StatPearls: Biochemistry, Serine Threonine Kinase.

Other names

PI3K/Akt and Ras/Raf/MEK/ERK pathwaysProtein Kinase B and MAPK cascadesGrowth factor signaling networksPro-survival and mitogenic signaling axes

Inhibition of phosphorylation cascades via ATP-competitive or allosteric inhibition of specific kinases (e.g., Akt, BRAF, MEK, PI3K) to arrest cell growth and induce apoptosis.